Inhaled insulin available in Spain:
This article was originally published in Clinica
Executive Summary
Most of Spain's three million diabetics can now opt to have the medical examination that should give them access to inhaled - rather than injected - insulin. From yesterday, Pfizer's Exubera became available in Spanish pharmacies, joining those in Germany, Ireland and the UK, Pfizer Espana told Clinica. The dry-powder delivery system is being provided under a full, national reimbursement regime, but only by prescription, following a medical examination: the technology will be barred to patients who have certain respiratory conditions and to children (the age threshold will be at the discretion of the physician, Clinica understands). Exubera received EU-wide market approval in January 2006.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.